Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 208 results.
User Information
Export Records
  1. 1.   TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells
  2. Kundu, Manjari; Greer, Yoshimi E; Lobanov, Alexei; Ridnour, Lisa; Donahue, Renee N; Ng, Yeap; Ratnayake, Shashi; White, Karley; Voeller, Donna; Weltz, Sarah; Chen, Qingrong; Lockett,Stephen; Cam, Maggie; Meerzaman, Daoud; Wink, David A; Weigert, Roberto; Lipkowitz, Stanley
  3. Cancer Letters. 2025, Jun 28; 620: 217692.
  1. 2.   HTLV-1 p13 Protein Hijacks Macrophage Polarization and Promotes T-Cell Recruitment
  2. Moles, Ramona; Omsland, Maria; Pise-Masison, Cynthia A; Subleski,Jeffrey; McVicar,Daniel; Sarkis, Sarkis; Gutowska, Anna; Schifanella, Luca; Doster, Melvin; Washington-Parks, Robyn; Ciminale, Vincenzo; Franchini, Genoveffa
  3. Viruses. 2025, Mar 26; 17(4): 471.
  1. 3.   Non-steroidal anti-inflammatory drug use and inflammatory markers associated with gallbladder dysplasia: A case-control analysis within a series of patients undergoing cholecystectomy
  2. Rosa, Lorena; Cook, Paz; Pfeiffer, Ruth M; Kemp,Troy; Hildesheim, Allan; Pehlivanoglu, Burcin; Adsay, Volkan; Bellolio, Enrique; Araya, Juan Carlos; Pinto,Ligia; Ferreccio, Catterina; Aguayo, Gloria; Viñuela, Eduardo; Koshiol, Jill
  3. International Journal of Cancer. 2024, Oct 31;
  1. 4.   Role of physicochemical properties in silica nanoparticle-mediated immunostimulation
  2. Grunberger, Jason William; Newton,Hannah; Donohue,Duncan; Dobrovolskaia,Marina; Ghandehari, Hamidreza
  3. Nanotoxicology. 2024, Oct 26; 1-19.
  1. 5.   In vitro assessment of nanomedicines' propensity to cause palmar-plantar erythrodysesthesia: A Doxil vs. doxorubicin case study
  2. Cedrone,Edward; Ishaq, Abbas; Grabarnik, Emma; Edmondson,Elijah; Skoczen,Sarah; Neun,Barry; Freer, Matthew; Shuttleworth, Siannah; Sviland, Lisbet; Dickinson, Anne; Dobrovolskaia,Marina
  3. Nanomedicine : nanotechnology, biology, and medicine. 2024, Aug 22; 102780.
  1. 6.   Complete Rescue of HTLV-1p12KO Infectivity by Depletion of Monocytes Together with NK and CD8+ T Cells
  2. Gutowska, Anna; Sarkis, Sarkis; Rahman, Mohammad Arif; Goldfarbmuren,Kate; Moles, Ramona; Bissa, Massimiliano; Doster, Melvin; Washington-Parks, Robyn; McKinnon, Katherine; Silva de Castro, Isabela; Schifanella, Luca; Franchini, Genoveffa; Pise-Masison, Cynthia A
  3. Pathogens (Basel, Switzerland). 2024, Mar 29; 13(4):
  1. 7.   Immunostimulation of Fibrous Nucleic Acid Nanoparticles Can be Modulated through Aptamer-Based Functional Moieties: Unveiling the Structure-Activity Relationship and Mechanistic Insights
  2. Rebolledo, Laura P; Ke, Weina; Cedrone,Edward; Wang, Jian; Majithia, Krishna; Johnson, M Brittany; Dokholyan, Nikolay V; Dobrovolskaia,Marina; Afonin, Kirill A
  3. ACS Applied Materials & Interfaces. 2024, Feb 12;
  1. 8.   Live Imaging and Analysis of Meiotic Cytokinesis in Drosophila Testes
  2. Kunduri,Govind; Acharya,Jairaj
  3. Bio-Protocol. 2024, Jan 20; 14(2): e4918.
  1. 9.   First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Ra, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
  2. Leidner, Rom; Conlon, Kevin; McNeel, Douglas G; Wang-Gillam, Andrea; Gupta, Sumati; Wesolowski, Robert; Chaudhari, Monica; Hassounah, Nadia; Lee, Jong Bong; Ho Lee, Lang; O'Keeffe, Jessica A; Lewis, Nancy; Pavlakis,George; Thompson, John A
  3. Journal for Immunotherapy of Cancer. 2023, Oct; 11(10):
  1. 10.   CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity
  2. Jess, Jennifer; Yates, Bonnie; Dulau-Florea, Alina; Parker, Kevin; Inglefield,Jon; Lichtenstein, Dan; Schischlik, Fiorella; Ongkeko, Martin; Wang,Yanyu; Shahani, Shilpa; Cullinane, Ann; Smith, Hannah; Kane, Eli; Little, Lauren; Chen, Dong; Fry, Terry J; Shalabi, Haneen; Wang, Hao-Wei; Satpathy, Ansuman; Lozier, Jay; Shah, Nirali N
  3. Journal for Immunotherapy of Cancer. 2023, Jun; 11(6):
  1. 11.   Tumor eradication by hetIL-15 locoregional therapy correlates with an induced intratumoral CD103intCD11b+ dendritic cell population
  2. Stellas, Dimitris; Karaliota,Sevasti; Stravokefalou, Vasiliki; Angel, Matthew; Nagy,Bethany; Goldfarbmuren,Kate; Bergamaschi, Cristina; Felber,Barbara; Pavlakis,George
  3. Cell Reports. 2023, May 12; 42(5): 112501.
  1. 12.   RAGE has potential pathogenetic and prognostic value in non-intubated hospitalized patients with COVID-19
  2. Wick, Katherine D; Siegel, Lianne; Neaton, James D; Oldmixon, Cathryn; Lundgren, Jens; Dewar, Robin L; Lane, H Clifford; Thompson, B Taylor; Matthay, Michael A
  3. JCI Insight. 2022, Mar 17; 7(9):
  1. 13.   An In Vitro Assessment of Immunostimulatory Responses to Ten Model Innate Immune Response Modulating Impurities (IIRMIs) and Peptide Drug Product, Teriparatide
  2. Holley,Claire; Cedrone,Edward; Donohue,Duncan; Neun,Barry; Verthelyi, Daniela; Pang, Eric S.; Dobrovolskaia, Marina A.
  3. Molecules. 2021, Dec; 26(24):
  1. 14.   Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
  2. Conlon, Kevin; Watson, Dionysios C; Waldmann, Thomas A; Valentin,Antonio; Bergamaschi,Cristina; Felber,Barbara; Peer, Cody J; Figg, William D; Potter, E Lake; Roederer, Mario; McNeel, Douglas G; Thompson, John A; Gupta, Sumati; Leidner, Rom; Wang-Gillam, Andrea; Parikh, Nehal S; Long, Debby; Kurtulus, Sema; Ho Lee, Lang; Chowdhury, Niladri Roy; Bender, Florent; Pavlakis,George
  3. Journal for immunotherapy of cancer. 2021, Nov; 9(11):
  1. 15.   IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses
  2. Harper, Taylor A.; Bacot, Silvia M.; Fennell, Christie Jane; Matthews,Rebecca; Zhu, Christina; Yue, Peng; Benton, Alexander; Friedman, Devira; Akue, Adovi; KuKuruga, Mark A.; Lee, Shiowjen; Wang, Tao; Feldman, Gerald M.
  3. International Journal of Molecular Sciences. 2021, Nov; 22(21):
  1. 17.   Systemic IL-15, IFN-?, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
  2. Bergamaschi,Cristina; Terpos, Evangelos; Rosati,Margherita; Angel,Matthew; Bear,Jenifer; Stellas,Dimitris; Karaliota,Sevasti; Apostolakou, Filia; Bagratuni, Tina; Patseas, Dimitris; Gumeni, Sentiljana; Trougakos, Ioannis P; Dimopoulos, Meletios A; Felber,Barbara; Pavlakis,George
  3. Cell reports. 2021, Aug 10; 36(6): 109504.
  1. 18.   Consequences of hemophagocytic lymphohistiocytosis-like cytokine release syndrome toxicities and concurrent bacteremia
  2. Masih, Katherine E.; Ligon, John A.; Yates, Bonnie; Shalabi, Haneen; Little, Lauren; Islam, Zahin; Ombrello, Amanda K.; Inglefield,Jon; Nussenblatt, Veronique; Manion, Maura; Khan, Javed; Shah, Nirali N.
  3. Pediatric blood & cancer. 2021, Jul 26;
  1. 19.   Cytokines: From Clinical Significance to Quantification
  2. Liu, Chao; Chu, Dewei; Kalantar-Zadeh, Kourosh; George, Jacob; Young,Howard; Liu, Guozhen
  3. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2021, Jun 10;
  1. 20.   The Timing and Abundance of IL-2R beta (CD122) Expression Control Thymic iNKT Cell Generation and NKT1 Subset Differentiation
  2. Won, Hee Yeun; Kim, Hye Kyung; Crossman, Assiatu; Awasthi,Roackie; Gress, Ronald E.; Park, Jung-Hyun
  3. Frontiers in immunology. 2021, May 14; 12
  1. 21.   Co-Isolation of Cytokines and Exosomes: Implications for Immunomodulation Studies
  2. Benjamin-Davalos, Shawna; Koroleva, Marina; Allen, Cheryl L.; Ernstoff, Marc S.; La Shu, Shin
  3. Frontiers In Immunology. 2021, Apr 19; 12
  1. 22.   Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier
  2. Avila, Yelixza I.; Chandler, Morgan; Cedrone,Edward; Newton,Hannah; Richardson, Melina; Xu,Jie; Clogston,Jeffrey; Liptrott, Neill J.; Afonin, Kirill A.; Dobrovolskaia,Marina
  3. Molecules. 2021, Feb; 26(3):
  1. 23.   An immune-based biomarker signature is associated with mortality in COVID-19 patients
  2. Abers, Michael S; Delmonte, Ottavia M; Ricotta, Emily E; Fintzi, Jonathan; Fink,Dani; de Jesus, Adriana A; Zarember, Kol A; Alehashemi, Sara; Oikonomou, Vasileios; Desai, Jigar V; Canna, Scott W; Shakoory, Bita; Dobbs, Kerry; Imberti, Luisa; Sottini, Alessandra; Quiros-Roldan, Eugenia; Castelli, Francesco; Rossi, Camillo; Brugnoni, Duilio; Biondi, Andrea; Bettini, Laura R; D'Angio', Mariella; Bonfanti, Paolo; Castagnoli, Riccardo; Montagna, Daniela; Licari, Amelia; Marseglia, Gian Luigi; Gliniewicz, Emily; Shaw, Elana R; Kahle, Dana; Rastegar, Andre T; Stack, Michael A; Myint-Hpu, Katherine; Levinson, Susan L; DiNubile, Mark J; Chertow, Daniel W; Burbelo, Peter; Cohen, Jeffrey I; Calvo, Katherine R; Tsang, John S; Su, Helen C; Gallin, John I; Kuhns,Doug; Goldbach-Mansky, Raphaela; Lionakis, Michail S; Notarangelo, Luigi D
  3. JCI insight. 2021, Jan 11; 6(1): pii: 144455.
  1. 24.   Exploring the Potential Use of a PBMC-Based Functional Assay to Identify Predictive Biomarkers for Anti-PD-1 Immunotherapy
  2. Bacot, Silvia M.; Harper, Taylor A.; Matthews,Rebecca; Fennell, Christie Jane; Akue, Adovi; KuKuruga, Mark A.; Lee, Shiowjen; Wang, Tao; Feldman, Gerald M.
  3. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2020, DEC; 21(23):
  1. 25.   Overproduction of a dominant mutant of the conserved Era GTPase inhibits cell division in Escherichia coli
  2. Zhou, Xiaomei; Peters, Howard K; Li,Xintian; Costantino,Nina; Kumari,Vandana; Shi,Genbin; Tu, Chao; Cameron, Todd A; Haeusser, Daniel P; Vega, Daniel E; Ji, Xinhua; Margolin, William; Court,Don
  3. Journal of bacteriology. 2020, NOV; 202(21): pii: JB.00342-20.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel